Global Weight Loss Drugs Market Insights and Forecast to 2026

Publisher Name :
Date: 03-Jul-2020
No. of pages: 113
Inquire Before Buying

Weight Loss Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Weight Loss Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Weight Loss Drugs market is segmented into

- Liauid

- Tablets

Segment by Application, the Weight Loss Drugs market is segmented into

- Weight-reducing Aid

- Other

Regional and Country-level Analysis

The Weight Loss Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Weight Loss Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Weight Loss Drugs Market Share Analysis

Weight Loss Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Weight Loss Drugs business, the date to enter into the Weight Loss Drugs market, Weight Loss Drugs product introduction, recent developments, etc.

The major vendors covered:

- Roche

- GSK group

- Teva

- Sandoz(Novartis)

- STADA-VN J.V.Co., Ltd

- Hexal AG

- National Company For Pharmaceutical Industry

- Lunan Pharmaceutical Group Corporation

- Zein Pharmaceutical

- Hisun

- Taj Pharmaceuticals Ltd

- Kabir Life Sciences & Research

- Dm Pharma

- China Zhongshan Pharm

Global Weight Loss Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Weight Loss Drugs Product Introduction
1.2 Market Segments
1.3 Key Weight Loss Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Weight Loss Drugs Market Size Growth Rate by Type
1.4.2 Liauid
1.4.3 Tablets
1.5 Market by Application
1.5.1 Global Weight Loss Drugs Market Size Growth Rate by Application
1.5.2 Weight-reducing Aid
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Weight Loss Drugs Market Size, Estimates and Forecasts
2.1.1 Global Weight Loss Drugs Revenue 2015-2026
2.1.2 Global Weight Loss Drugs Sales 2015-2026
2.2 Global Weight Loss Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Weight Loss Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Weight Loss Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Weight Loss Drugs Competitor Landscape by Players
3.1 Weight Loss Drugs Sales by Manufacturers
3.1.1 Weight Loss Drugs Sales by Manufacturers (2015-2020)
3.1.2 Weight Loss Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Weight Loss Drugs Revenue by Manufacturers
3.2.1 Weight Loss Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Weight Loss Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Weight Loss Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Weight Loss Drugs Revenue in 2019
3.2.5 Global Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Weight Loss Drugs Price by Manufacturers
3.4 Weight Loss Drugs Manufacturing Base Distribution, Product Types
3.4.1 Weight Loss Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Weight Loss Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Weight Loss Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Weight Loss Drugs Market Size by Type (2015-2020)
4.1.1 Global Weight Loss Drugs Sales by Type (2015-2020)
4.1.2 Global Weight Loss Drugs Revenue by Type (2015-2020)
4.1.3 Weight Loss Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Weight Loss Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Weight Loss Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Weight Loss Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Weight Loss Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Weight Loss Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Weight Loss Drugs Market Size by Application (2015-2020)
5.1.1 Global Weight Loss Drugs Sales by Application (2015-2020)
5.1.2 Global Weight Loss Drugs Revenue by Application (2015-2020)
5.1.3 Weight Loss Drugs Price by Application (2015-2020)
5.2 Weight Loss Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Weight Loss Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Weight Loss Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Weight Loss Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Weight Loss Drugs by Country
6.1.1 North America Weight Loss Drugs Sales by Country
6.1.2 North America Weight Loss Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Weight Loss Drugs Market Facts & Figures by Type
6.3 North America Weight Loss Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Weight Loss Drugs by Country
7.1.1 Europe Weight Loss Drugs Sales by Country
7.1.2 Europe Weight Loss Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Weight Loss Drugs Market Facts & Figures by Type
7.3 Europe Weight Loss Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Weight Loss Drugs by Region
8.1.1 Asia Pacific Weight Loss Drugs Sales by Region
8.1.2 Asia Pacific Weight Loss Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Weight Loss Drugs Market Facts & Figures by Type
8.3 Asia Pacific Weight Loss Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Weight Loss Drugs by Country
9.1.1 Latin America Weight Loss Drugs Sales by Country
9.1.2 Latin America Weight Loss Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Weight Loss Drugs Market Facts & Figures by Type
9.3 Central & South America Weight Loss Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Weight Loss Drugs by Country
10.1.1 Middle East and Africa Weight Loss Drugs Sales by Country
10.1.2 Middle East and Africa Weight Loss Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Weight Loss Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Weight Loss Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Weight Loss Drugs Products Offered
11.1.5 Roche Related Developments
11.2 GSK group
11.2.1 GSK group Corporation Information
11.2.2 GSK group Description and Business Overview
11.2.3 GSK group Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK group Weight Loss Drugs Products Offered
11.2.5 GSK group Related Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Description and Business Overview
11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Weight Loss Drugs Products Offered
11.3.5 Teva Related Developments
11.4 Sandoz(Novartis)
11.4.1 Sandoz(Novartis) Corporation Information
11.4.2 Sandoz(Novartis) Description and Business Overview
11.4.3 Sandoz(Novartis) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sandoz(Novartis) Weight Loss Drugs Products Offered
11.4.5 Sandoz(Novartis) Related Developments
11.5 STADA-VN J.V.Co., Ltd
11.5.1 STADA-VN J.V.Co., Ltd Corporation Information
11.5.2 STADA-VN J.V.Co., Ltd Description and Business Overview
11.5.3 STADA-VN J.V.Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 STADA-VN J.V.Co., Ltd Weight Loss Drugs Products Offered
11.5.5 STADA-VN J.V.Co., Ltd Related Developments
11.6 Hexal AG
11.6.1 Hexal AG Corporation Information
11.6.2 Hexal AG Description and Business Overview
11.6.3 Hexal AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Hexal AG Weight Loss Drugs Products Offered
11.6.5 Hexal AG Related Developments
11.7 National Company For Pharmaceutical Industry
11.7.1 National Company For Pharmaceutical Industry Corporation Information
11.7.2 National Company For Pharmaceutical Industry Description and Business Overview
11.7.3 National Company For Pharmaceutical Industry Sales, Revenue and Gross Margin (2015-2020)
11.7.4 National Company For Pharmaceutical Industry Weight Loss Drugs Products Offered
11.7.5 National Company For Pharmaceutical Industry Related Developments
11.8 Lunan Pharmaceutical Group Corporation
11.8.1 Lunan Pharmaceutical Group Corporation Corporation Information
11.8.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
11.8.3 Lunan Pharmaceutical Group Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Products Offered
11.8.5 Lunan Pharmaceutical Group Corporation Related Developments
11.9 Zein Pharmaceutical
11.9.1 Zein Pharmaceutical Corporation Information
11.9.2 Zein Pharmaceutical Description and Business Overview
11.9.3 Zein Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Zein Pharmaceutical Weight Loss Drugs Products Offered
11.9.5 Zein Pharmaceutical Related Developments
11.10 Hisun
11.10.1 Hisun Corporation Information
11.10.2 Hisun Description and Business Overview
11.10.3 Hisun Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hisun Weight Loss Drugs Products Offered
11.10.5 Hisun Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Weight Loss Drugs Products Offered
11.1.5 Roche Related Developments
11.12 Kabir Life Sciences & Research
11.12.1 Kabir Life Sciences & Research Corporation Information
11.12.2 Kabir Life Sciences & Research Description and Business Overview
11.12.3 Kabir Life Sciences & Research Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Kabir Life Sciences & Research Products Offered
11.12.5 Kabir Life Sciences & Research Related Developments
11.13 Dm Pharma
11.13.1 Dm Pharma Corporation Information
11.13.2 Dm Pharma Description and Business Overview
11.13.3 Dm Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Dm Pharma Products Offered
11.13.5 Dm Pharma Related Developments
11.14 China Zhongshan Pharm
11.14.1 China Zhongshan Pharm Corporation Information
11.14.2 China Zhongshan Pharm Description and Business Overview
11.14.3 China Zhongshan Pharm Sales, Revenue and Gross Margin (2015-2020)
11.14.4 China Zhongshan Pharm Products Offered
11.14.5 China Zhongshan Pharm Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Weight Loss Drugs Market Estimates and Projections by Region
12.1.1 Global Weight Loss Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Weight Loss Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Weight Loss Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Weight Loss Drugs Sales Forecast (2021-2026)
12.2.2 North America: Weight Loss Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Weight Loss Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Weight Loss Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Weight Loss Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Weight Loss Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Weight Loss Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Weight Loss Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Weight Loss Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Weight Loss Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Weight Loss Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Weight Loss Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Weight Loss Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Weight Loss Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Weight Loss Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Weight Loss Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Weight Loss Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Weight Loss Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Weight Loss Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Weight Loss Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Weight Loss Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Weight Loss Drugs Market Segments
Table 2. Ranking of Global Top Weight Loss Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Weight Loss Drugs Market Size Growth Rate by Type 2020-2026 (K Tablets) & (US$ Million)
Table 4. Major Manufacturers of Liauid
Table 5. Major Manufacturers of Tablets
Table 6. Global Weight Loss Drugs Market Size Growth Rate by Application 2020-2026 (K Tablets)
Table 7. Global Weight Loss Drugs Market Size by Region (K Tablets) & (US$ Million): 2020 VS 2026
Table 8. Global Weight Loss Drugs Sales by Regions 2015-2020 (K Tablets)
Table 9. Global Weight Loss Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Weight Loss Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Weight Loss Drugs Sales by Manufacturers (2015-2020) (K Tablets)
Table 12. Global Weight Loss Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Weight Loss Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Weight Loss Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Drugs as of 2019)
Table 15. Weight Loss Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Weight Loss Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Weight Loss Drugs Price (2015-2020) (USD/Tablet)
Table 18. Weight Loss Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Weight Loss Drugs Product Type
Table 20. Date of International Manufacturers Enter into Weight Loss Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Weight Loss Drugs Sales by Type (2015-2020) (K Tablets)
Table 23. Global Weight Loss Drugs Sales Share by Type (2015-2020)
Table 24. Global Weight Loss Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Weight Loss Drugs Revenue Share by Type (2015-2020)
Table 26. Weight Loss Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Tablet)
Table 27. Global Weight Loss Drugs Sales by Application (2015-2020) (K Tablets)
Table 28. Global Weight Loss Drugs Sales Share by Application (2015-2020)
Table 29. North America Weight Loss Drugs Sales by Country (2015-2020) (K Tablets)
Table 30. North America Weight Loss Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Weight Loss Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Weight Loss Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Weight Loss Drugs Sales by Type (2015-2020) (K Tablets)
Table 34. North America Weight Loss Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Weight Loss Drugs Sales by Application (2015-2020) (K Tablets)
Table 36. North America Weight Loss Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Weight Loss Drugs Sales by Country (2015-2020) (K Tablets)
Table 38. Europe Weight Loss Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Weight Loss Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Weight Loss Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Weight Loss Drugs Sales by Type (2015-2020) (K Tablets)
Table 42. Europe Weight Loss Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Weight Loss Drugs Sales by Application (2015-2020) (K Tablets)
Table 44. Europe Weight Loss Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Weight Loss Drugs Sales by Region (2015-2020) (K Tablets)
Table 46. Asia Pacific Weight Loss Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Weight Loss Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Weight Loss Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Weight Loss Drugs Sales by Type (2015-2020) (K Tablets)
Table 50. Asia Pacific Weight Loss Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Weight Loss Drugs Sales by Application (2015-2020) (K Tablets)
Table 52. Asia Pacific Weight Loss Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Weight Loss Drugs Sales by Country (2015-2020) (K Tablets)
Table 54. Latin America Weight Loss Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Weight Loss Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Weight Loss Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Weight Loss Drugs Sales by Type (2015-2020) (K Tablets)
Table 58. Latin America Weight Loss Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Weight Loss Drugs Sales by Application (2015-2020) (K Tablets)
Table 60. Latin America Weight Loss Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Weight Loss Drugs Sales by Country (2015-2020) (K Tablets)
Table 62. Middle East and Africa Weight Loss Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Weight Loss Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Weight Loss Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Weight Loss Drugs Sales by Type (2015-2020) (K Tablets)
Table 66. Middle East and Africa Weight Loss Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Weight Loss Drugs Sales by Application (2015-2020) (K Tablets)
Table 68. Middle East and Africa Weight Loss Drugs Sales Market Share by Application (2015-2020)
Table 69. Roche Corporation Information
Table 70. Roche Description and Major Businesses
Table 71. Roche Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 72. Roche Product
Table 73. Roche Recent Development
Table 74. GSK group Corporation Information
Table 75. GSK group Description and Major Businesses
Table 76. GSK group Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 77. GSK group Product
Table 78. GSK group Recent Development
Table 79. Teva Corporation Information
Table 80. Teva Description and Major Businesses
Table 81. Teva Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 82. Teva Product
Table 83. Teva Recent Development
Table 84. Sandoz(Novartis) Corporation Information
Table 85. Sandoz(Novartis) Description and Major Businesses
Table 86. Sandoz(Novartis) Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 87. Sandoz(Novartis) Product
Table 88. Sandoz(Novartis) Recent Development
Table 89. STADA-VN J.V.Co., Ltd Corporation Information
Table 90. STADA-VN J.V.Co., Ltd Description and Major Businesses
Table 91. STADA-VN J.V.Co., Ltd Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 92. STADA-VN J.V.Co., Ltd Product
Table 93. STADA-VN J.V.Co., Ltd Recent Development
Table 94. Hexal AG Corporation Information
Table 95. Hexal AG Description and Major Businesses
Table 96. Hexal AG Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 97. Hexal AG Product
Table 98. Hexal AG Recent Development
Table 99. National Company For Pharmaceutical Industry Corporation Information
Table 100. National Company For Pharmaceutical Industry Description and Major Businesses
Table 101. National Company For Pharmaceutical Industry Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 102. National Company For Pharmaceutical Industry Product
Table 103. National Company For Pharmaceutical Industry Recent Development
Table 104. Lunan Pharmaceutical Group Corporation Corporation Information
Table 105. Lunan Pharmaceutical Group Corporation Description and Major Businesses
Table 106. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 107. Lunan Pharmaceutical Group Corporation Product
Table 108. Lunan Pharmaceutical Group Corporation Recent Development
Table 109. Zein Pharmaceutical Corporation Information
Table 110. Zein Pharmaceutical Description and Major Businesses
Table 111. Zein Pharmaceutical Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 112. Zein Pharmaceutical Product
Table 113. Zein Pharmaceutical Recent Development
Table 114. Hisun Corporation Information
Table 115. Hisun Description and Major Businesses
Table 116. Hisun Weight Loss Drugs Production (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 117. Hisun Product
Table 118. Hisun Recent Development
Table 119. Taj Pharmaceuticals Ltd Corporation Information
Table 120. Taj Pharmaceuticals Ltd Description and Major Businesses
Table 121. Taj Pharmaceuticals Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 122. Taj Pharmaceuticals Ltd Product
Table 123. Taj Pharmaceuticals Ltd Recent Development
Table 124. Kabir Life Sciences & Research Corporation Information
Table 125. Kabir Life Sciences & Research Description and Major Businesses
Table 126. Kabir Life Sciences & Research Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 127. Kabir Life Sciences & Research Product
Table 128. Kabir Life Sciences & Research Recent Development
Table 129. Dm Pharma Corporation Information
Table 130. Dm Pharma Description and Major Businesses
Table 131. Dm Pharma Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 132. Dm Pharma Product
Table 133. Dm Pharma Recent Development
Table 134. China Zhongshan Pharm Corporation Information
Table 135. China Zhongshan Pharm Description and Major Businesses
Table 136. China Zhongshan Pharm Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 137. China Zhongshan Pharm Product
Table 138. China Zhongshan Pharm Recent Development
Table 139. Global Weight Loss Drugs Sales Forecast by Regions (2021-2026) (K Tablets)
Table 140. Global Weight Loss Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Weight Loss Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Weight Loss Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Weight Loss Drugs Sales Forecast by Country (2021-2026) (K Tablets)
Table 144. North America: Weight Loss Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Weight Loss Drugs Sales Forecast by Country (2021-2026) (K Tablets)
Table 146. Europe: Weight Loss Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Weight Loss Drugs Sales Forecast by Region (2021-2026) (K Tablets)
Table 148. Asia Pacific: Weight Loss Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Weight Loss Drugs Sales Forecast by Country (2021-2026) (K Tablets)
Table 150. Latin America: Weight Loss Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Weight Loss Drugs Sales Forecast by Country (2021-2026) (K Tablets)
Table 152. Middle East and Africa: Weight Loss Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Weight Loss Drugs Players
Table 157. Weight Loss Drugs Customers List
Table 158. Weight Loss Drugs Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Weight Loss Drugs Product Picture
Figure 2. Global Weight Loss Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Liauid Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Weight Loss Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Weight-reducing Aid
Figure 7. Other
Figure 8. Weight Loss Drugs Report Years Considered
Figure 9. Global Weight Loss Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Weight Loss Drugs Sales 2015-2026 (K Tablets)
Figure 11. Global Weight Loss Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Weight Loss Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global Weight Loss Drugs Sales Market Share by Region in 2019
Figure 14. Global Weight Loss Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global Weight Loss Drugs Revenue Market Share by Region in 2019
Figure 16. Global Weight Loss Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Weight Loss Drugs Revenue in 2019
Figure 18. Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Weight Loss Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global Weight Loss Drugs Sales Market Share by Type in 2019
Figure 21. Global Weight Loss Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global Weight Loss Drugs Revenue Market Share by Type in 2019
Figure 23. Global Weight Loss Drugs Market Share by Price Range (2015-2020)
Figure 24. Global Weight Loss Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global Weight Loss Drugs Sales Market Share by Application in 2019
Figure 26. Global Weight Loss Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global Weight Loss Drugs Revenue Market Share by Application in 2019
Figure 28. North America Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 29. North America Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Weight Loss Drugs Sales Market Share by Country in 2019
Figure 31. North America Weight Loss Drugs Revenue Market Share by Country in 2019
Figure 32. U.S. Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 33. U.S. Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 35. Canada Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Weight Loss Drugs Market Share by Type in 2019
Figure 37. North America Weight Loss Drugs Market Share by Application in 2019
Figure 38. Europe Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 39. Europe Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Weight Loss Drugs Sales Market Share by Country in 2019
Figure 41. Europe Weight Loss Drugs Revenue Market Share by Country in 2019
Figure 42. Germany Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 43. Germany Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 45. France Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 47. U.K. Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 49. Italy Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 51. Russia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Weight Loss Drugs Market Share by Type in 2019
Figure 53. Europe Weight Loss Drugs Market Share by Application in 2019
Figure 54. Asia Pacific Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 55. Asia Pacific Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Weight Loss Drugs Sales Market Share by Region in 2019
Figure 57. Asia Pacific Weight Loss Drugs Revenue Market Share by Region in 2019
Figure 58. China Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 59. China Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 61. Japan Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 63. South Korea Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 65. India Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 67. Australia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 69. Taiwan Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 71. Indonesia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 73. Thailand Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 75. Malaysia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 77. Philippines Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 79. Vietnam Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Weight Loss Drugs Market Share by Type in 2019
Figure 81. Asia Pacific Weight Loss Drugs Market Share by Application in 2019
Figure 82. Latin America Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 83. Latin America Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Weight Loss Drugs Sales Market Share by Country in 2019
Figure 85. Latin America Weight Loss Drugs Revenue Market Share by Country in 2019
Figure 86. Mexico Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 87. Mexico Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 89. Brazil Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 91. Argentina Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Weight Loss Drugs Market Share by Type in 2019
Figure 93. Latin America Weight Loss Drugs Market Share by Application in 2019
Figure 94. Middle East and Africa Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 95. Middle East and Africa Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Weight Loss Drugs Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Weight Loss Drugs Revenue Market Share by Country in 2019
Figure 98. Turkey Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 99. Turkey Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 101. Saudi Arabia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 103. U.A.E Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Weight Loss Drugs Market Share by Type in 2019
Figure 105. Middle East and Africa Weight Loss Drugs Market Share by Application in 2019
Figure 106. North America Weight Loss Drugs Sales Growth Rate Forecast (2021-2026) (K Tablets)
Figure 107. North America Weight Loss Drugs Revenue Growth Rate Forecast (2
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs